Latest Blogs

Anne Katz, PhD, RN, FAAN
Jul 22, 2019
Acting Out in the Face of a New Diagnosis
It was challenging to counsel a patient who responded to his cancer diagnosis by having affairs.
International Perspectives
Jul 19, 2019
Building Bridges: The Need for Mentors and Multidisciplinarity in Oncology
Dr. Zuhir Bodalal wanted to be able to offer chances to patients who would otherwise be out of options, so he needed to find a way to bridge different worlds.
Don S. Dizon, MD, FACP, FASCO
Jul 11, 2019
Consensus Doesn’t Require Deference
Consensus among a multidisciplinary team may not be easy, but it is, ultimately, the goal. That, in and of itself, is the definition of quality care.
Miriam Knoll, MD
Jul 08, 2019
New Paradigms for Developing Skills in a Technology-Driven Medical World
How does a group of talented, busy surgeons find the time to change their surgical paradigm? Dr. Nabil P. Rizk and I had an enlightening conversation about cost, value, quality of care, and process improvement.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the delegate representing ASCO at the AMA-House of Delegates.

Jun 20, 2019
ASCO’s Delegation at the AMA House of Delegates: So Much More to Do
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Nov 19, 2018
AMA House of Delegates: This Timeline Grows Short
At a recent meeting, the ASCO delegation to the AMA House of Delegates presented concerns focused on the Competitive Acquisition Program (CAP), among a variety of other issues.
Jun 22, 2018
So Busy and So Worthwhile: ASCO and the AMA House of Delegates
At the most recent meeting, ASCO's delegation to the AMA House of Delegates were involved in resolutions related to Pharmacy Benefit Managers, opioids, billing for survivorship care plans, alcohol as a modifiable risk for cancer, and more.
Nov 20, 2017
Aloha from the ASCO AMA House of Delegates
The ASCO delegation was very busy at the American Medical Association House of Delegates recent interim meeting.
Jun 29, 2017
AMA House of Delegates: These are Impactful Times
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Nov 28, 2016
Become Engaged, Stay Engaged: More Important Than Ever
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...

Pages